Literature DB >> 21948460

Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs).

Antonio Sica1, Chiara Porta, Sara Morlacchi, Stefania Banfi, Laura Strauss, Monica Rimoldi, Maria Grazia Totaro, Elena Riboldi.   

Abstract

The construction of an inflammatory microenvironment provides the fuel for cancer development and progression. Hence, solid tumors promote the expansion and the recruitment of leukocyte populations, among which tumor-associated myeloid cells (TAMCs) represent a paradigm for cancer-promoting inflammation. TAMCs group heterogeneous phagocytic populations stemming from a common myeloid progenitor (CMP), that orchestrate various aspects of cancer, including: diversion and skewing of adaptive responses; immunosuppression; cell growth; angiogenesis; matrix deposition and remodelling; construction of a metastatic niche and actual metastasis. Several evidence indicate that TAMCs show plasticity and/or functional heterogeneity, suggesting that tumour-derived factors promote their functional "reprogramming" towards protumoral activities. While recent studies have attempted to address the role of microenvironment signals, the interplay between cancer cells, innate and adaptive immunity is now emerging as a crucial step of the TAMCs reprogramming. Here we discuss the evidence for the differentiation of TAMCs during the course of tumor progression and the molecular mechanisms that regulate such event.

Entities:  

Year:  2011        PMID: 21948460      PMCID: PMC3399067          DOI: 10.1007/s12307-011-0091-6

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  172 in total

1.  A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

Authors:  Hyun-Jeong Ko; Yeon-Jeong Kim; Yun-Sun Kim; Woo-Sung Chang; Sung-Youl Ko; Sun-Young Chang; Shimon Sakaguchi; Chang-Yuil Kang
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 2.  The dendritic cell-tumor cross-talk in cancer.

Authors:  Yuting Ma; Laetitia Aymeric; Clara Locher; Guido Kroemer; Laurence Zitvogel
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

3.  p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

Authors:  Alessandra Saccani; Tiziana Schioppa; Chiara Porta; Subhra K Biswas; Manuela Nebuloni; Luca Vago; Barbara Bottazzi; Mario P Colombo; Alberto Mantovani; Antonio Sica
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

Review 4.  Myeloid-derived suppressor cells in human cancer.

Authors:  Srinivas Nagaraj; Dmitry I Gabrilovich
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

Review 5.  The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.

Authors:  Je-In Youn; Dmitry I Gabrilovich
Journal:  Eur J Immunol       Date:  2010-11       Impact factor: 5.532

6.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

9.  The yin-yang of tumor-associated neutrophils.

Authors:  Alberto Mantovani
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

10.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

View more
  42 in total

1.  Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.

Authors:  Sunil Singhal; Jason Stadanlick; Michael J Annunziata; Abhishek S Rao; Pratik S Bhojnagarwala; Shaun O'Brien; Edmund K Moon; Edward Cantu; Gwenn Danet-Desnoyers; Hyun-Jeong Ra; Leslie Litzky; Tatiana Akimova; Ulf H Beier; Wayne W Hancock; Steven M Albelda; Evgeniy B Eruslanov
Journal:  Sci Transl Med       Date:  2019-02-13       Impact factor: 17.956

Review 2.  Spotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxide.

Authors:  Andrea Predonzani; Bianca Calì; Andrielly Hr Agnellini; Barbara Molon
Journal:  World J Exp Med       Date:  2015-05-20

3.  Participation of Tumor-Associated Myeloid Cells in Progression of Amelanotic Melanoma (RMM Tumor Line) in F344 Rats, with Particular Reference to MHC Class II- and CD163-Expressing Cells.

Authors:  A Bondoc; H M Golbar; M Pervin; C Katou-Ichikawa; M Tanaka; T Izawa; M Kuwamura; J Yamate
Journal:  Cancer Microenviron       Date:  2017-06-16

Review 4.  One microenvironment does not fit all: heterogeneity beyond cancer cells.

Authors:  Ik Sun Kim; Xiang H-F Zhang
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

Review 5.  Targeting amino acid metabolism in cancer growth and anti-tumor immune response.

Authors:  Elitsa Ananieva
Journal:  World J Biol Chem       Date:  2015-11-26

6.  Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.

Authors:  Jacek R Wilczyński; Marek Nowak
Journal:  Exp Suppl       Date:  2022

7.  Monocytes and macrophages in cancer: development and functions.

Authors:  David M Richards; Jan Hettinger; Markus Feuerer
Journal:  Cancer Microenviron       Date:  2012-11-24

8.  Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma.

Authors:  Peng Zhang; Jason Miska; Catalina Lee-Chang; Aida Rashidi; Wojciech K Panek; Shejuan An; Markella Zannikou; Aurora Lopez-Rosas; Yu Han; Ting Xiao; Katarzyna C Pituch; Deepak Kanojia; Irina V Balyasnikova; Maciej S Lesniak
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-11       Impact factor: 11.205

9.  Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

Authors:  Evgeniy B Eruslanov; Pratik S Bhojnagarwala; Jon G Quatromoni; Tom Li Stephen; Anjana Ranganathan; Charuhas Deshpande; Tatiana Akimova; Anil Vachani; Leslie Litzky; Wayne W Hancock; José R Conejo-Garcia; Michael Feldman; Steven M Albelda; Sunil Singhal
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

10.  Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study.

Authors:  Anjali Gupta; Taofik Oyekunle; Omolola Salako; Adetola Daramola; Olusegun Alatise; Gabriel Ogun; Adewale Adeniyi; April Deveaux; Veeral Saraiya; Allison Hall; Omobolaji Ayandipo; Thomas Olajide; Olalekan Olasehinde; Olukayode Arowolo; Adewale Adisa; Oludolapo Afuwape; Aralola Olusanya; Aderemi Adegoke; Trygve O Tollefsbol; Donna Arnett; Michael J Muehlbauer; Christopher B Newgard; Tomi Akinyemiju
Journal:  Oncotarget       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.